Sanna Bastiano's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 8, 2022
- Accession no.
- 0000899243-22-014360
- Filed
- Apr 8, 2022
- Trade date
- Apr 7, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $154.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sanna BastianoCIK 0001829069 | Officer (EVP, Cell & Genetic Therapies) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2022 | Common Stock | SSaleDisposed | −204 | $275.71F2,F3 | −$56,244.84 | 43,139 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −327 | $276.39F2,F4 | −$90,379.53 | 42,812 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −30 | $277.02 | −$8,310.6 | 42,782 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $275.71 (range $275.00 to $275.95).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $276.39 (range $276.00 to $276.78).
Referenced by the price of 1 transaction in Table I.